N-SIDE, provider of innovative software and strategic consulting services, announced that AstraZeneca has signed an agreement to implement the N-SIDE Suite for Clinical Trials. Within the scope of this agreement, AstraZeneca will use specifically the N-SIDE Supply and Dashboard Apps in order to design, plan and monitor their clinical trial supply chain.
John Murray, supply chain transformation lead at AstraZeneca, commented: “N-SIDE’s Suite provides a tremendous opportunity for AstraZeneca to collaborate across key areas of clinical development and deliver the best studies for our patients.”
Thanks to the N-SIDE Suite for Clinical Trials, AstraZeneca will achieve a centralisation of its clinical supply chain management. The N-SIDE solution will support both strategic decision-making during protocol design as well as operational planning and change management of ongoing trials. The business intelligence dashboards will be used for real-time trial monitoring, results visualisation and supporting cross-department communication.
“We are proud to further our collaboration with AstraZeneca as they implement the N-SIDE Suite for Clinical Trials to manage their clinical supply chain,” stated Jacques Parlongue, N-SIDE CEO. N-SIDE has provided consulting services for AstraZeneca clinical trial supply optimisation since 2017.
The N-SIDE Suite for Clinical Trials is a cutting-edge, Cloud-based software that enables clinical trial managers to future-proof their clinical trial supply chain management while minimizing costs, drug waste and risk. With interconnected applications, the N-SIDE Suite for Clinical Trials uses advanced analytics, including optimisation and machine learning, to support strategic and operational decision-making, as well as facilitate trial monitoring with real-time data and knowledge sharing.